iKang Healthcare Group, Inc. (KANG) Releases Earnings Results
iKang Healthcare Group, Inc. (NASDAQ:KANG) issued its earnings results on Thursday. The medical research company reported $0.06 earnings per share (EPS) for the quarter, Morningstar.com reports. The business had revenue of $115.60 million for the quarter. iKang Healthcare Group had a negative net margin of 2.58% and a negative return on equity of 3.19%.
Shares of iKang Healthcare Group (NASDAQ KANG) traded down 4.17% during midday trading on Friday, hitting $13.80. 87,679 shares of the stock were exchanged. The stock’s 50 day moving average is $13.87 and its 200 day moving average is $14.20. iKang Healthcare Group has a 12-month low of $11.70 and a 12-month high of $18.94. The firm’s market cap is $890.79 million.
Separately, BidaskClub upgraded shares of iKang Healthcare Group from a “sell” rating to a “hold” rating in a research note on Tuesday, August 15th.
A number of institutional investors have recently modified their holdings of the business. GLG Partners LP boosted its holdings in iKang Healthcare Group by 15.5% in the 2nd quarter. GLG Partners LP now owns 1,754,570 shares of the medical research company’s stock valued at $21,529,000 after purchasing an additional 235,056 shares during the period. FIL Ltd boosted its holdings in iKang Healthcare Group by 45.4% in the 2nd quarter. FIL Ltd now owns 360,922 shares of the medical research company’s stock valued at $4,429,000 after purchasing an additional 112,615 shares during the period. SG Americas Securities LLC boosted its holdings in iKang Healthcare Group by 14.6% in the 2nd quarter. SG Americas Securities LLC now owns 44,608 shares of the medical research company’s stock valued at $547,000 after purchasing an additional 5,700 shares during the period. Athos Capital Ltd bought a new stake in iKang Healthcare Group in the 2nd quarter valued at $8,622,000. Finally, First Manhattan Co. boosted its holdings in iKang Healthcare Group by 101.7% in the 2nd quarter. First Manhattan Co. now owns 1,040,043 shares of the medical research company’s stock valued at $12,761,000 after purchasing an additional 524,318 shares during the period. 29.70% of the stock is owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY NOTICE: “iKang Healthcare Group, Inc. (KANG) Releases Earnings Results” was published by American Banking News and is the property of of American Banking News. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark and copyright legislation. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2017/09/15/ikang-healthcare-group-inc-kang-releases-earnings-results.html.
About iKang Healthcare Group
iKang Healthcare Group, Inc provides preventive healthcare solutions, including a range of medical examinations services and value-added services, including disease screening, dental services and other services in China. The Company’s segments include medical examinations and other medical services, and dental services.
Receive News & Ratings for iKang Healthcare Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.